Human Embryonic Stem Cells (hESC) - A Global Market Overview

Date: July 22, 2010
Pages: 216
Price:
US$ 4,680.00
License [?]:
Publisher: Industry Experts
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: HEFADAF556DEN
Leaflet:

Download PDF Leaflet

Human Embryonic Stem Cells (hESC) - A Global Market Overview
Embryonic stem cell (hESC) research has attracted a lot of attention the world over and the controversy surrounding it just does not seem to die down. Stem cells are unspecialized cells that are capable of differentiating into any other cell type. In addition to being crucial for humans, stem cells also form an important tool in research for finding cures for a host of diseases. Adult, umbilical cord blood and embryos constitute the three sources of stem cells, of which embryonic stem cells have been the subject of major research activities.

Embryonic Stem Cell Technologies analyzed in this study include Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other. The report also analyzes the market for hESC therapeutic areas including Central Nervous System (CNS), Tissue Engineering, Oncology, Cardiology and Other Disease Areas.The worldwide market for hESCs is estimated at US$3.8 billion in 2010. Growing at a robust CAGR of 24.8% during the period 2007-2015, the market is projected to reach US$10.7 billion by 2015, .

The report reviews, analyses and projects the hESCs market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 12 independent countries across North America – United States, Canada and Mexico; Europe – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe; Asia-Pacific –India, China, Japan, Australia and Rest of Asia-Pacific.

This 216 page global market report includes 106 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value in USD by geographic regions and the product segments. The study also profiles 41 key global players and 55 major players across North America – 28; Europe – 15; Asia-Pacific – 10 and Rest of World - 2. The report also provides the listing of the companies engaged in research, technology development, manufacturing and the supply of hESCs. The global list of companies covers addresses, contact numbers and the website addresses of 184 companies.
1. GLOBAL MARKET PERSPECTIVE

1.1 Introduction

1.2 Product Segmentation
  1.2.1 Technologies of hESCs
    1.2.1.1 Stem Cell Transplants
      Infarcted Myocardium to be repaired by Human Embryonic Stem Cell Transplantation
      Oligodendrocyte Progenitor Cell Transplants Derived from Human Embryonic Stem Cells Enhance Recovery after Cervical Spinal Cord Injury
      Human Embryonic Stem Cell-Derived Cardiomyocytes Transplantation Improves Myocardial Performance in Infarcted Rat Hearts
    1.2.1.2 Cell Based Genomics
      Genomic Alterations in Cultured Human Embryonic Stem Cells
      Gene Expression in Human Embryonic Stem Cell Lines: Unique Molecular Signature
      GeneChip Analysis of Human Embryonic Stem Cell Differentiation into Hemangioblasts: An In Silico Dissection of Mixed Phenotypes
    1.2.1.3 Xenotransplantation
    1.2.1.4 Other Stem Cell Technologies
  1.2.2 Therapeutic Areas of hESCs
    1.2.2.1 Central Nervous System
    1.2.2.2 Tissue Engineering
      Endochondral Bone Tissue Engineering Using Embryonic Stem Cells
      Bone Tissue Engineering in an Orthotopic Defect
      Discussion
    1.2.2.3 Oncology
      Embryonic Stem Cells Reveal Secret Growth Formula of Oncogene
    1.2.2.4 Cardiology
    1.2.2.5 Other Therapeutic Areas
      Blood Disorders
      Diabetes
      Muscular Dystrophy
      Stem Cell Therapy for Spinal Cord Injury
  1.2.3 Pros and Cons of Embryonic Stem Cell Research

1.3 Snapshot on Global hESC Laws and Patents
  1.3.1 The United States
    Patent on Human Embryonic Stem Cells Rejected After Consumer Groups' Appeal
  1.3.2 Europe
    Stem Cell Patent Rejected by Europe
  1.3.3 Asia-Pacific
    China
    Laws and Regulations
    Cultural Views
    Australia
    India
    Indonesia
    Japan
    Taiwan
    Patent Policy
    Thailand
    Singapore
    South Korea

1.4 A Glance at Existing Stem Cell Research Policies Worldwide
  1.4.1 hESC Research Policy by Region
    North America
    Europe
    Asia-Pacific
    Rest of World
  1.4.2 Status of Stem Cell Research

1.5 Market Trends
  Human Embryonic Stem Cells Hold Promises for Medical Advances
  hESC In Toxicology Applications
  Stem Cells Hold Promise to Predict Disease and Drug Toxicity
  Scientists Create More Pluripotent Human Embryonic Stem Cells
  Latest Trends in Treating HIV and AIDS with Stem Cell Therapies
  Embryonic Stem Cells Promise New Cures
  Does Bill Expanding Obama's Embryonic Stem Cell Research Order Promote Cloning?
  Israeli Stem Cell Researchers Achieve Breakthrough in Cell Growth Method
  Reactive Oxygen Species Enhance Differentiation of hESCs into Mesendodermal Lineage
  Federal Policy Allows Funding for New hESC Lines but not all Investigators are Happy with the Changes
  Human Skin Grown from Stem Cells to Help Burns Victims
  UCI Embryonic Stem Cell Therapy Restores Walking Ability in Rats with Neck Injuries
  Human Embryonic Stem Cell Differentiation on Periodontal Ligament Fibroblasts
  Technique Enables Efficient Gene Splicing in Human Embryonic Stem Cells
  Human Sperm Created from Embryonic Stem Cells
  hESC Technologies and Drug Discovery
  Stem Cell Therapy for Blindness
  Expansion and Differentiation of hESC to Endoderm Progeny in a Microcarrier Stirred-Suspension Culture
  Geron Commences Human Embryonic Stem Cell Therapy for Spinal Cord Injuries
  Nanotechnology for Regenerative Medicine: Nanomaterials for Stem Cell Imaging
  Therapeutic Potential of hESC in Parkinson’s disease

1.6 Key Global Players
  Advanced Cell Technology, Inc
  Amgen
  Angel Biotechnology
  Australian Stem Cell Centre
  Axiogenesis AG
  BD Biosciences
  BioTime
  Boehringer-Ingelheim GmbH
  Cellartis AB
  CellResearch Corporation Pte Ltd
  Cellular Dynamics International
  ESTOOLS
  Gamida Cell Ltd.
  GE Healthcare
  Geron Corporation
  GlobalStem Inc
  International Stem Cell Corporation
  Millipore Corporation
  National Human Neural Stem Cell Resource
  Novartis AG
  Novo Nordisk A/B
  PerkinElmer Inc.
  Pfizer
  R&D Systems, Inc.
  Regenics A/S
  Reliance Life Sciences
  RNL BIO
  SA Biosciences Corporation
  Sanofi-Aventis
  Scottish Stem Cell Network
  SinoCells BioTechnologies Co., Ltd.
  Stem Cell Network
  Stem Cell Sciences KK
  StemCells Inc.
  Stemina Biomarker Discovery, Inc.
  StemTech International Sdn Bhd
  Taiwan Society for Stem Cell Research
  Thermo Fisher Scientific Inc
  UK National Stem Cell Network
  UK Stem Cell Bank (UKNSCB)
  ViaCell, Inc.

1.7 Key Business Trends
  BioTime, Inc Acquires ES Cell International Pte Ltd
  PerkinElmer to Acquire Signature Genomic Laboratories, LLC
  Proxeon Acquired by Thermo Fisher Scientific
  Stemgent, Pfizer in a Collaboration Research and Licensing Agreement
  Thermo Fisher Scientific Takes Over Ahura Scientific
  Human Embryonic Stem Cells with Enhanced Pluripotency Created by Scientists
  Stemcell Technologies Inc Releases Two NEW Human Treg Cell Isolation Kits
  Pfizer Acquires Wyeth
  Thermo Fisher Scientific Acquires B.R.A.H.M.S.
  PerkinElmer Takes Over Prenatal and Newborn Screening Laboratory in India
  StemCells, Inc Plans to Enhance Cell-Based Technologies for Pharmaceutical Industry and Research Applications
  Thermo Fisher Scientific to Acquire Biolab
  Embryome Sciences, Inc Enters into an Agreement with Reproductive Genetics Institute
  StemCells, Inc. to Acquire Cell-Based Drug Discovery Platforms and Related Businesses of Stem Cell Sciences plc
  Geron Gets the Green Signal from FDA to Begin World's First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
  Advanced Cell Technology, Inc and CHA Biotech Co, Ltd in a Joint Venture
  BD™ Human Pluripotent Stem Cell Sorting and Analysis Kit Launched by BD Biosciences
  BioTime to Work with Longevity Center on Regenerative Medicine Research
  Embryome Sciences, Inc. Acquires Exclusive License for ACTCellerate Technology
  Thermo Fisher Scientific Acquires Affinity BioReagents
  Thermo Fisher Scientific Acquires Open Biosystems
  MedCell Joins Forces with NovaThera
  Pfizer Acquires Encysive Pharmaceuticals Inc
  BD Acquires Cytopeia
  Advanced Cell Technology and Catholic Healthcare West Sign Clinical Agreement
  BI Biotech India Pvt. Ltd, GlobalStem Inc Enter into Partnership

1.8 Global Market Overview
  1.8.1 Market Overview by hESC Technology
  1.8.2 Market Overview by hESC Therapeutic Area
  1.8.3 hESC Technology Market Overview by Global Region
    1.8.3.1 Stem Cell Transplants
    1.8.3.2 Cell Based Genomics
    1.8.3.3 Xenotransplants
    1.8.3.4 Other Stem Cell Technologies
  1.8.4 hESC Therapeutic Area Market Overview by Global Region
    1.8.4.1 Central Nervous System (CNS)
    1.8.4.2 Tissue Engineering
    1.8.4.3 Oncology
    1.8.4.4 Cardiology
    1.8.4.5 Other Disease Areas

2. REGIONAL MARKET PERSPECTIVE

2.1 Regional Market Overview
  2.1.1 North America
    2.1.1.1 Market Overview by North American Region
    2.1.1.2 Market Overview by hESC Technology
    2.1.1.3 Market Overview by hESC Therapeutic Area
    2.1.1.4 hESC Technology Market Overview by North American Region
      Stem Cell Transplants
      Cell Based Genomics
      Xenotransplants
      Other Stem Cell Technologies
    2.1.1.5 Major Market Players
      Amgen
      Advanced Cell Technology, Inc
      Americans for Cures Foundation
      Angioblast Systems, Inc
      BD Biosciences
      BioTime
      California Stem Cell
      Cellular Dynamics International
      Geron Corporation
      GlobalStem Inc
      International Society for Stem Cell Research
      International Stem Cell Corporation
      Millipore Corporation
      National Human Neural Stem Cell Resource
      PerkinElmer Inc.
      Pfizer
      R&D Systems, Inc.
      SA Biosciences Corporation
      Stem Cell Network (Canada)
      Stem Cell Technologies (Canada)
      Stem Cell Therapy International Corporation
      StemCells Inc.
      Stemina Biomarker Discovery, Inc.
      The New York Stem Cell Foundation
      Thermo Fisher Scientific Inc
      ViaCell, Inc.
      ViaCyte
      WiCell International Stem Cell (WISC) Bank
    2.1.1.6 North American Market Overview by Country
      The United States
      Canada
      Mexico
  2.1.2 Europe
    2.1.2.1 Market Overview by European Region
    2.1.2.2 Market Overview by hESC Technology
    2.1.2.3 Market Overview by hESC Therapeutic Area
    2.1.2.4 hESC Technology Market Overview by European Region
      Stem Cell Transplants
      Cell Based Genomics
      Xenotransplants
      Other Stem Cell Technologies
    2.1.2.5 Major Market Players
      Angel Biotechnology (United Kingdom)
      Axiogenesis AG (Germany)
      Boehringer-Ingelheim GmbH (Germany)
      Cellartis AB (Sweden)
      ESTOOLS (United Kingdom)
      GE Healthcare (United Kingdom)
      Novartis AG (Switzerland)
      Novo Nordisk A/B (Denmark)
      Regenics A/S (Norway)
      Sanofi-Aventis (France)
      Scottish Stem Cell Network (United Kingdom)
      Stemride International Ltd (United Kingdom)
      TATAA Biocenter (Sweden)
      UK National Stem Cell Network (United Kingdom)
      UK Stem Cell Bank (UKNSCB) (United Kingdom)
    2.1.2.6 European Market Overview by Country
      The United Kingdom
      Germany
      France
      Spain
      Sweden
      Rest of Europe
  2.1.3 Asia-Pacific
    2.1.3.1 Market Overview by Asia-Pacific Region
    2.1.3.2 Market Overview by hESC Technology
    2.1.3.3 Market Overview by hESC Therapeutic Area
    2.1.3.4 hESC Technology Market Overview by Asia-Pacific Region
      Stem Cell Transplants
      Cell Based Genomics
      Xenotransplants
      Other Stem Cell Technologies
    2.1.3.5 Major Market Players
      Australian Stem Cell Centre (Australia)
      CellResearch Corporation Pte Ltd (Singapore)
      National Center for Biological Sciences (India)
      New South Wales Stem Cell Network (Australia)
      Reliance Life Sciences (India)
      RNL BIO (South Korea)
      SinoCells BioTechnologies Co., Ltd. (China)
      Stem Cell Sciences KK (Japan)
      StemTech International Sdn Bhd (Malaysia)
      Taiwan Society for Stem Cell Research (Taiwan)
    2.1.3.6 Asia-Pacific Market Overview by Country
      India
      Role of Governing Bodies
      Latest Trends in Stem Cells Therapy
      Future of Stem Cells in India Primed for Growth
      Indian Stem Cells’ Company Scenario
      Outlook
      China
      Japan
      Australia
      Rest of Asia-Pacific
  2.1.4 Rest of World
    2.1.4.1 Market Overview by Rest of World Region
    2.1.4.2 Market Overview by hESC Technology
    2.1.4.3 Market Overview by hESC Therapeutic Area
    2.1.4.4 Major Market Players
      Cell Cure Neurosciences Ltd. (Israel)
      Gamida Cell Ltd. (Israel)

3. GUIDE TO THE INDUSTRY

3.1 North America
  3.1.1 Canada
  3.1.2 United States
3.2 Europe
  3.2.1 Denmark
  3.2.2 France
  3.2.3 Germany
  3.2.4 Norway
  3.2.5 Spain
  3.2.6 Sweden
  3.2.7 Switzerland
  3.2.8 The Netherlands
  3.2.9 United Kingdom
3.3 Asia-Pacific
  3.3.1 Australia
  3.3.2 China
  3.3.3 India
  3.3.4 Japan
  3.3.5 Korea
  3.3.6 Malaysia
  3.3.7 Singapore
  3.3.8 South Korea
  3.3.9 Taiwan
  3.3.10 Thailand
3.4 Rest of World
  3.4.1 Israel
  3.4.2 South Africa

4. ANNEXURE

4.1 Research methodology
4.2 The Questionnaire
4.3 Feedback

CHARTS & GRAPHS

GLOBAL MARKET PERSPECTIVE
Chart 1: Stem Cell Types – Properties
Chart 2: Stem Cell Research (2009): The Nations with Embryos Created for Research by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 3: Stem Cell Research (2009): The Nations with Existing Stem Cell Lines by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 4: Stem Cell Research (2009): The nations with No Explicit Stem Cell Research Policy by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 5: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in USD Million
Chart 6: Global Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 7: Glance at 2007, 2010 and 2015 Global Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other
Chart 8: Global Human Embryonic Stem Cells Market Analysis (2007-2015) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other in USD Million
Chart 9: Glance at 2007, 2010 and 2015 Global Human Embryonic Stem Cells Market Share (%) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other
Chart 10: Global Stem Cell Transplants Market Analysis (2007-2015) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 11: Glance at 2007, 2010 and 2015 Global Stem Cell Transplants Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 12: Global Cell Based Genomics Market Analysis (2007-2015) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 13: Glance at 2007, 2010 and 2015 Global Cell Based Genomics Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 14: Global Xenotransplants Market Analysis (2007-2015) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 15: Glance at 2007, 2010 and 2015 Global Xenotransplants Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 16: Global Other Stem Cell Technologies Market Analysis (2007-2015) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 17: Glance at 2007, 2010 and 2015 Global Other Stem Cell Technologies Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 18: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in CNS by Geographic Region –North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 19: Glance at 2007, 2010 and 2015 Global CNS Market Share (%) of Human Embryonic Stem Cells by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 20: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in Tissue Engineering by Geographic Region –North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 21: Glance at 2007, 2010 and 2015 Global Tissue Engineering Market Share (%) of Human Embryonic Stem Cells by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 22: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in Oncology by Geographic Region –North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 23: Glance at 2007, 2010 and 2015 Global Oncology Market Share (%) of Human Embryonic Stem Cells by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 24: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in Cardiology by Geographic Region –North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 25: Glance at 2007, 2010 and 2015 Global Cardiology Market Share (%) of Human Embryonic Stem Cells by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 26: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in Other Disease Areas by Geographic Region –North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 27: Glance at 2007, 2010 and 2015 Global Other Disease Areas Market Share (%) of Human Embryonic Stem Cells by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

REGIONAL MARKET PERSPECTIVE
Chart 28: The Projection of Largest Regions in terms of Market Growth for Human Embryonic Stem Cells by Geography – Asia-Pacific, Europe and North America
Chart 29: Global Human Embryonic Stem Cells Market Analysis (2007-2015) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 30: Glance at 2007, 2010 and 2015 Global Human Embryonic Stem Cells Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

NORTH AMERICA
Chart 31: North American Human Embryonic Stem Cells Market Analysis (2007-2015) by Geographic Region – United States, Canada and Mexico in USD Million
Chart 32: Glance at 2007, 2010 and 2015 North American Human Embryonic Stem Cells Market Share (%) by Geographic Region – United States, Canada and Mexico
Chart 33: North American Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 34: Glance at 2007, 2010 and 2015 North American Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other
Chart 35: North American Human Embryonic Stem Cells Market Analysis (2007-2015) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other in USD Million
Chart 36: Glance at 2007, 2010 and 2015 North American Human Embryonic Stem Cells Market Share (%)by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other
Chart 37: North American Stem Cell Transplants Market Analysis (2007-2015) by Geographic Region – United States, Canada and Mexico in USD Million
Chart 38: Glance at 2007, 2010 and 2015 North American Stem Cell Transplants Market Share (%) by Geographic Region – United States, Canada and Mexico
Chart 39: North American Cell Based Genomics Market Analysis (2007-2015) by Geographic Region – United States, Canada and Mexico in USD Million
Chart 40: Glance at 2007, 2010 and 2015 North American Cell Based Genomics Market Share (%) by Geographic Region – United States, Canada and Mexico
Chart 41: North American Xenotransplants Market Analysis (2007-2015) by Geographic Region – United States, Canada and Mexico in USD Million
Chart 42: Glance at 2007, 2010 and 2015 North American Xenotransplants Market Share (%) by Geographic Region – United States, Canada and Mexico
Chart 43: North American Other Stem Cell Technologies Market Analysis (2007-2015) by Geographic Region – United States, Canada and Mexico in USD Million
Chart 44: Glance at 2007, 2010 and 2015 North American Other Stem Cell Technologies Market Share (%) by Geographic Region – United States, Canada and Mexico

The United States
Chart 45: United States Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 46: Glance at 2007, 2010 and 2015 United States Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Canada
Chart 47: Canadian Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 48: Glance at 2007, 2010 and 2015 Canadian Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Mexico
Chart 49: Mexican Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 50: Glance at 2007, 2010 and 2015 Mexican Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

EUROPE
Chart 51: European Human Embryonic Stem Cells Market Analysis (2007-2015) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe in USD Million
Chart 52: Glance at 2007, 2010 and 2015 European Human Embryonic Stem Cells Market Share (%) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe
Chart 53: European Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 54: Glance at 2007, 2010 and 2015 European Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other
Chart 55: European Human Embryonic Stem Cells Market Analysis (2007-2015) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other in USD Million
Chart 56: Glance at 2007, 2010 and 2015 European Human Embryonic Stem Cells Market Share (%) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other
Chart 57: European Stem Cell Transplants Market Analysis (2007-2015) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe in USD Million
Chart 58: Glance at 2007, 2010 and 2015 European Stem Cell Transplants Market Share (%) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe
Chart 59: European Cell Based Genomics Market Analysis (2007-2015) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe in USD Million
Chart 60: Glance at 2007, 2010 and 2015 European Cell Based Genomics Market Share (%) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe
Chart 61: European Xenotransplants Market Analysis (2007-2015) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe in USD Million
Chart 62: Glance at 2007, 2010 and 2015 European Xenotransplants Market Share (%) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe
Chart 63: European Other Stem Cell Technologies Market Analysis (2007-2015) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe in USD Million
Chart 64: Glance at 2007, 2010 and 2015 European Other Stem Cell Technologies Market Share (%) by Geographic Region – United Kingdom, Germany, France, Spain, Sweden and Rest of Europe

United Kingdom
Chart 65: United Kingdom Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 66: Glance at 2007, 2010 and 2015 United Kingdom Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Germany
Chart 67: German Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 68: Glance at 2007, 2010 and 2015 German Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

France
Chart 69: French Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 70: Glance at 2007, 2010 and 2015 French Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Spain
Chart 71: Spanish Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 72: Glance at 2007, 2010 and 2015 Spanish Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Sweden
Chart 73: Swedish Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 74: Glance at 2007, 2010 and 2015 Swedish Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Rest of Europe
Chart 75: Rest of Europe Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 76: Glance at 2007, 2010 and 2015 Rest of Europe Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

ASIA-PACIFIC
Chart 77: Asia-Pacific Human Embryonic Stem Cells Market Analysis (2007-2015) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific in USD Million
Chart 78: Glance at 2007, 2010 and 2015 Asia-Pacific Human Embryonic Stem Cells Market Share (%) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific
Chart 79: Asia-Pacific Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 80: Glance at 2007, 2010 and 2015 Asia-Pacific Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other
Chart 81: Asia-Pacific Human Embryonic Stem Cells Market Analysis (2007-2015) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other in USD Million
Chart 82: Glance at 2007, 2010 and 2015 Asia-Pacific Human Embryonic Stem Cells Market Share (%) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other
Chart 83: Asia-Pacific Stem Cell Transplants Market Analysis (2007-2015) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific in USD Million
Chart 84: Glance at 2007, 2010 and 2015 Asia-Pacific Stem Cell Transplants Market Share (%) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific
Chart 85: Asia-Pacific Cell Based Genomics Market Analysis (2007-2015) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific in USD Million
Chart 86: Glance at 2007, 2010 and 2015 Asia-Pacific Cell Based Genomics Market Share (%) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific
Chart 87: Asia-Pacific Xenotransplants Market Analysis (2007-2015) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific in USD Million 170
Chart 88: Glance at 2007, 2010 and 2015 Asia-Pacific Xenotransplants Market Share (%) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific
Chart 89: Asia-Pacific Other Stem Cell Technologies Market Analysis (2007-2015) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific in USD Million
Chart 90: Glance at 2007, 2010 and 2015 Asia-Pacific Other Stem Cell Technologies Market Share (%) by Geographic Region – India, China, Japan, Australia and Rest of Asia-Pacific

India
Chart 91: Indian Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 92: Glance at 2007, 2010 and 2015 Indian Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

China
Chart 93: Chinese Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 94: Glance at 2007, 2010 and 2015 Chinese Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Japan
Chart 95: Japanese Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 96: Glance at 2007, 2010 and 2015 Japanese Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Australia
Chart 97: Australian Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 98: Glance at 2007, 2010 and 2015 Australian Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Rest of Asia-Pacific
Chart 99: Rest of Asia-Pacific Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 100: Glance at 2007, 2010 and 2015 Rest of Asia-Pacific Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

REST OF WORLD
Chart 101: Rest of World Human Embryonic Stem Cells Market Analysis (2007-2015) by Geographic Region – Brazil, Israel, Columbia, Africa and Other in USD Million
Chart 102: Glance at 2007, 2010 and 2015 Rest of World Human Embryonic Stem Cells Market Share (%) by Geographic Region – Brazil, Israel, Columbia, Africa and Other
Chart 103: Rest of World Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
Chart 104: Glance at 2007, 2010 and 2015 Rest of World Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology – Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other
Chart 105: Rest of World Human Embryonic Stem Cells Market Analysis (2007-2015) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other in USD Million
Chart 106: Glance at 2007, 2010 and 2015 Rest of World Human Embryonic Stem Cells Market Share (%) by Therapeutic Area – CNS, Tissue Engineering, Oncology, Cardiology and Other
Skip to top


Ask Your Question

Human Embryonic Stem Cells (hESC) - A Global Market Overview
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: